Investors

 

Key to long-term value: discipline, execution and consistent communication.

Analyst coverage

FirmAnalystPhone
BarclaysGeoff Meacham(212) 526-2795
Cowen & Co.Chris Shibutani, M.D.(617) 946-3733
Deutsche Bank Securities Inc.Andrew Peters(415) 262-2002
Goldman, Sachs & Co.Terence Flynn(212) 357-5057
Jefferies & Co.Eun Yang, Ph.D.(212) 284-2264
JMP SecuritiesMichael G. King, Jr.(212) 906-3520
JPMorgan Chase & Co.Anupam Rama(212) 622-0900
Leerink Partners LLCMichael Schmidt, Ph.D.(617) 918-4588
RBC Capital Markets, LLCMichael J. Yee(415) 633-8522
SunTrust Robinson HumphreyYatin  Suneja(212) 319-5887
William Blair & Company, LLCY. Katherine Xu, Ph.D.(212) 237-2758
ARIAD Pharmaceuticals, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding ARIAD Pharmaceuticals, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of ARIAD Pharmaceuticals, Inc. or its management. ARIAD Pharmaceuticals, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.